Table 3

Potential predictors for retreatment

No revision
(n=23)
Revision
(n=8)
p Value
Female gender21 (91.3%)8 (100%)1.0
Age35.5 (12.6)29.3 (5.7)0.191
Race 0.0002
 African-American0/55/5
 Caucasian23/262/26
BMI continuous (kg/m2)36.8 (10.4)44.3 (9.9)0.103
BMI classNormal: 6Normal: 0 0.031
Class I: 7Class I: 0
Class II: 3Class II: 2
Class III: 7Class III: 6
CVP (IJV)10.1 (4.5)9.6 (4.6)0.797
Post-stenting torcular pressure (mm Hg)*16.4 (6.1)17.4 (4.8)0.671
Post-stenting gradient pressure (mm Hg)*3.0 (3.1)0.9 (1.2)0.097
Post-stenting IJV pressure (mm Hg)*13.2 (5.2)16.4 (5.1)0.152
Endocrine disorder7 (30.4%)1 (12.5%)0.642
Steroid immunosuppressive4 (17.4%)0 (0.0%)0.550
Intrinsic etiology2 (8.7%)0 (0.0%)1.0
Stent size (mm)†
 81430.218
 772
 923
  • Values are mean (SD) unless indicated otherwise.

  • Bold type indicates statistical significance.

  • *Data for post-intervention pressures are missing for one patient.

  • †Stent used is the self-expanding Zilver biliary stent (Cook Medical, Bloomington, Indiana, USA).

  • BMI, body mass index; CVP, central venous pressure; IJV, internal jugular vein.